Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Influenza

Free Subscription Articles published in Eur J Epidemiol Retrieve available abstracts of 72 articles: HTML format

Single Articles

August 2023
1. LIN S, Gao X, Degenhardt F, Qian Y, et al
   Genome-wide epistasis study highlights genetic interactions influencing severity of COVID-19.
   Eur J Epidemiol. 2023;38:883-889.
   PubMed     Abstract available
   
   
   
2. NORREDAM M, Islamoska S, Petersen JH, Benfield T, et al
   COVID-19 mortality and use of intensive care among ethnic minorities - a national register-based Danish population study.
   Eur J Epidemiol. 2023;38:891-899.
   PubMed     Abstract available
   
   
   May 2023
3. ANDERSEN MP, Mills EHA, Meddis A, Sorensen KK, et al
   All-cause mortality among Danish nursing home residents before and during the COVID-19 pandemic: a nationwide cohort study.
   Eur J Epidemiol. 2023;38:523-531.
   PubMed     Abstract available
   
   
   April 2023
4. BUTTIA C, Llanaj E, Raeisi-Dehkordi H, Kastrati L, et al
   Prognostic models in COVID-19 infection that predict severity: a systematic review.
   Eur J Epidemiol. 2023;38:355-372.
   PubMed     Abstract available
   
   
   March 2023
5. POZO-MARTIN F, Beltran Sanchez MA, Muller SA, Diaconu V, et al
   Comparative effectiveness of contact tracing interventions in the context of the COVID-19 pandemic: a systematic review.
   Eur J Epidemiol. 2023;38:243-266.
   PubMed     Abstract available
   
   
   
6. BEUKENHORST AL, Koch CM, Hadjichrysanthou C, Alter G, et al
   SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.
   Eur J Epidemiol. 2023;38:237-242.
   PubMed     Abstract available
   
   
   
7. BELL M, Ekbom A, Linder M
   COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm.
   Eur J Epidemiol. 2023;38:301-311.
   PubMed     Abstract available
   
   
   February 2023
8. BOWYER RCE, Huggins C, Toms R, Shaw RJ, et al
   Characterising patterns of COVID-19 and long COVID symptoms: evidence from nine UK longitudinal studies.
   Eur J Epidemiol. 2023;38:199-210.
   PubMed     Abstract available
   
   
   January 2023
9. RODIAH I, Vanella P, Kuhlmann A, Jaeger VK, et al
   Age-specific contribution of contacts to transmission of SARS-CoV-2 in Germany.
   Eur J Epidemiol. 2023;38:39-58.
   PubMed     Abstract available
   
   
   
10. ANGELINI M, Teglia F, Astolfi L, Casolari G, et al
    Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis.
    Eur J Epidemiol. 2023;38:31-38.
    PubMed     Abstract available
    
    
    December 2022
11. JOYAL-DESMARAIS K, Stojanovic J, Kennedy EB, Enticott JC, et al
    How well do covariates perform when adjusting for sampling bias in online COVID-19 research? Insights from multiverse analyses.
    Eur J Epidemiol. 2022;37:1233-1250.
    PubMed     Abstract available
    
    
    November 2022
12. SIEURIN J, Branden G, Magnusson C, Hergens MP, et al
    A population-based cohort study of sex and risk of severe outcomes in covid-19.
    Eur J Epidemiol. 2022;37:1159-1169.
    PubMed     Abstract available
    
    
    October 2022
13. SAMUEL A
    Re: Carrat et al. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.
    Eur J Epidemiol. 2022;37:1083-1084.
    PubMed    
    
    
    
14. BERGHOFER A, Rotter G, Pankert J, Icke K, et al
    SARS-CoV-2 infections in professional orchestra and choir musicians-a prospective cohort study.
    Eur J Epidemiol. 2022;37:1061-1070.
    PubMed     Abstract available
    
    
    
15. BANHOLZER N, Lison A, Ozcelik D, Stadler T, et al
    The methodologies to assess the effectiveness of non-pharmaceutical interventions during COVID-19: a systematic review.
    Eur J Epidemiol. 2022;37:1003-1024.
    PubMed     Abstract available
    
    
    
16. MATHIEU C, Pambrun E, Benard-Laribiere A, Noize P, et al
    Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study.
    Eur J Epidemiol. 2022;37:1049-1059.
    PubMed     Abstract available
    
    
    
17. EBELING M, Acosta E, Caswell H, Meyer AC, et al
    Years of life lost during the Covid-19 pandemic in Sweden considering variation in life expectancy by level of geriatric care.
    Eur J Epidemiol. 2022;37:1025-1034.
    PubMed     Abstract available
    
    
    
18. BUCYIBARUTA G, Blangiardo M, Konstantinoudis G
    Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study.
    Eur J Epidemiol. 2022;37:1071-1081.
    PubMed     Abstract available
    
    
    
19. MCDONALD SA, Lagerweij GR, de Boer P, de Melker HE, et al
    The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years.
    Eur J Epidemiol. 2022;37:1035-1047.
    PubMed     Abstract available
    
    
    September 2022
20. IOANNIDIS JPA
    Estimating conditional vaccine effectiveness.
    Eur J Epidemiol. 2022;37:885-890.
    PubMed     Abstract available
    
    
    
21. JOLLANT F, Blanc-Brisset I, Cellier M, Ambar Akkaoui M, et al
    Temporal trends in calls for suicide attempts to poison control centers in France during the COVID-19 pandemic: a nationwide study.
    Eur J Epidemiol. 2022;37:901-913.
    PubMed     Abstract available
    
    
    August 2022
22. GARCIA-ALBENIZ X, Del Amo J, Polo R, Morales-Asencio JM, et al
    Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19.
    Eur J Epidemiol. 2022;37:789-796.
    PubMed     Abstract available
    
    
    
23. SCHONS M, Pilgram L, Reese JP, Stecher M, et al
    The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics.
    Eur J Epidemiol. 2022;37:849-870.
    PubMed     Abstract available
    
    
    
24. GELDSETZER P, Mukama T, Jawad NK, Riffe T, et al
    Sex differences in the mortality rate for coronavirus disease 2019 compared to other causes of death: an analysis of population-wide data from 63 countries.
    Eur J Epidemiol. 2022;37:797-806.
    PubMed     Abstract available
    
    
    June 2022
25. NARRES M, Claessen H, Kvitkina T, Rosenbauer J, et al
    Hospitalisation rate and mortality among people with and without diabetes during the COVID-19 pandemic year 2020.
    Eur J Epidemiol. 2022;37:587-590.
    PubMed     Abstract available
    
    
    May 2022
26. VERBERK JDM, de Hoog MLA, Westerhof I, van Goethem S, et al
    Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries.
    Eur J Epidemiol. 2022;37:549-561.
    PubMed     Abstract available
    
    
    
27. CASPERSEN IH, Magnus P, Trogstad L
    Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort.
    Eur J Epidemiol. 2022;37:539-548.
    PubMed     Abstract available
    
    
    March 2022
28. LEVIN AT, Jylhava J, Religa D, Shallcross L, et al
    COVID-19 prevalence and mortality in longer-term care facilities.
    Eur J Epidemiol. 2022;37:227-234.
    PubMed     Abstract available
    
    
    
29. AXFORS C, Ioannidis JPA
    Infection fatality rate of COVID-19 in community-dwelling elderly populations.
    Eur J Epidemiol. 2022;37:235-249.
    PubMed     Abstract available
    
    
    February 2022
30. HERGENS MP, Bell M, Haglund P, Sundstrom J, et al
    Risk factors for COVID-19-related death, hospitalization and intensive care: a population-wide study of all inhabitants in Stockholm.
    Eur J Epidemiol. 2022;37:157-165.
    PubMed     Abstract available
    
    
    
31. HVIDE HK, Johnsen J
    COVID-19 and mental health: a longitudinal population study from Norway.
    Eur J Epidemiol. 2022;37:167-172.
    PubMed     Abstract available
    
    
    December 2021
32. COLEMAN T, Sarian A, Grad S
    Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.
    Eur J Epidemiol. 2021;36:1245-1246.
    PubMed    
    
    
    
33. MULOT M, Segalas C, Leyrat C, Besancon L, et al
    Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.
    Eur J Epidemiol. 2021;36:1243-1244.
    PubMed    
    
    
    
34. SUBRAMANIAN SV, Kumar A
    The Authors' Reply: Need for a multi-pronged population-level strategy to manage SARS-CoV-2 infection.
    Eur J Epidemiol. 2021;36:1247-1251.
    PubMed    
    
    
    
35. GIANICOLO E, Wollschlager D, Blettner M
    Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.
    Eur J Epidemiol. 2021;36:1241-1242.
    PubMed    
    
    
    
36. BJORK J, Modig K, Kahn F, Ahlbom A, et al
    Revival of ecological studies during the COVID-19 pandemic.
    Eur J Epidemiol. 2021;36:1225-1229.
    PubMed    
    
    
    
37. WOLLSCHLAGER D, Gianicolo E, Blettner M, Hamann R, et al
    Association of COVID-19 mortality with COVID-19 vaccination rates in Rhineland-Palatinate (Germany) from calendar week 1 to 20 in the year 2021: a registry-based analysis.
    Eur J Epidemiol. 2021;36:1231-1236.
    PubMed     Abstract available
    
    
    
38. SUBRAMANIAN SV, Kumar A
    Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States.
    Eur J Epidemiol. 2021;36:1237-1240.
    PubMed    
    
    
    July 2021
39. ESPENHAIN L, Tribler S, Svaerke Jorgensen C, Holm Hansen C, et al
    Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.
    Eur J Epidemiol. 2021;36:715-725.
    PubMed     Abstract available
    
    
    
40. BELLUCO S, Mancin M, Marzoli F, Bortolami A, et al
    Prevalence of SARS-CoV-2 RNA on inanimate surfaces: a systematic review and meta-analysis.
    Eur J Epidemiol. 2021;36:685-707.
    PubMed     Abstract available
    
    
    
41. GOUDSMIT J, van den Biggelaar AHJ, Koudstaal W, Hofman A, et al
    Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program.
    Eur J Epidemiol. 2021;36:753-762.
    PubMed     Abstract available
    
    
    
42. MCDONALD SA, Miura F, Vos ERA, van Boven M, et al
    Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands.
    Eur J Epidemiol. 2021;36:735-739.
    PubMed     Abstract available
    
    
    
43. TELLE K, Jorgensen SB, Hart R, Greve-Isdahl M, et al
    Secondary attack rates of COVID-19 in Norwegian families: a nation-wide register-based study.
    Eur J Epidemiol. 2021;36:741-748.
    PubMed     Abstract available
    
    
    
44. REICHER S, Ratzon R, Ben-Sahar S, Hermoni-Alon S, et al
    Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel.
    Eur J Epidemiol. 2021;36:727-734.
    PubMed     Abstract available
    
    
    June 2021
45. IOANNIDIS JPA
    Over- and under-estimation of COVID-19 deaths.
    Eur J Epidemiol. 2021;36:581-588.
    PubMed     Abstract available
    
    
    
46. LICHER S, Terzikhan N, Splinter MJ, Velek P, et al
    Design, implementation and initial findings of COVID-19 research in the Rotterdam Study: leveraging existing infrastructure for population-based investigations on an emerging disease.
    Eur J Epidemiol. 2021;36:649-654.
    PubMed     Abstract available
    
    
    
47. LUNDBERG JO, Zeberg H
    Longitudinal variability in mortality predicts COVID-19 deaths.
    Eur J Epidemiol. 2021;36:599-603.
    PubMed     Abstract available
    
    
    
48. NAFILYAN V, Islam N, Mathur R, Ayoubkhani D, et al
    Ethnic differences in COVID-19 mortality during the first two waves of the Coronavirus Pandemic: a nationwide cohort study of 29 million adults in England.
    Eur J Epidemiol. 2021;36:605-617.
    PubMed     Abstract available
    
    
    
49. POZO-MARTIN F, Weishaar H, Cristea F, Hanefeld J, et al
    The impact of non-pharmaceutical interventions on COVID-19 epidemic growth in the 37 OECD member states.
    Eur J Epidemiol. 2021;36:629-640.
    PubMed     Abstract available
    
    
    
50. FERENCI T
    Different approaches to quantify years of life lost from COVID-19.
    Eur J Epidemiol. 2021;36:589-597.
    PubMed     Abstract available
    
    
    
51. SCHMITZ T, Meisinger C, Kirchberger I, Thilo C, et al
    Impact of COVID-19 pandemic lockdown on myocardial infarction care.
    Eur J Epidemiol. 2021;36:619-627.
    PubMed     Abstract available
    
    
    May 2021
52. BOTTCHER L, D'Orsogna MR, Chou T
    Using excess deaths and testing statistics to determine COVID-19 mortalities.
    Eur J Epidemiol. 2021;36:545-558.
    PubMed     Abstract available
    
    
    
53. BATTY GD, Deary IJ, Gale CR
    Pre-pandemic cognitive function and COVID-19 mortality: prospective cohort study.
    Eur J Epidemiol. 2021;36:559-564.
    PubMed     Abstract available
    
    
    April 2021
54. BUSHMAN M, Worby C, Chang HH, Kraemer MUG, et al
    Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China.
    Eur J Epidemiol. 2021;36:429-439.
    PubMed     Abstract available
    
    
    
55. DE SOUZA FSH, Hojo-Souza NS, da Silva CM, Guidoni DL, et al
    Second wave of COVID-19 in Brazil: younger at higher risk.
    Eur J Epidemiol. 2021;36:441-443.
    PubMed    
    
    
    March 2021
56. BERGMAN J, Ballin M, Nordstrom A, Nordstrom P, et al
    Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study.
    Eur J Epidemiol. 2021;36:287-298.
    PubMed     Abstract available
    
    
    
57. TERZIKHAN N, Hofman A, Goudsmit J, Ikram MA, et al
    External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population.
    Eur J Epidemiol. 2021;36:319-324.
    PubMed     Abstract available
    
    
    
58. ELLIOTT J, Bodinier B, Whitaker M, Delpierre C, et al
    COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors.
    Eur J Epidemiol. 2021;36:299-309.
    PubMed     Abstract available
    
    
    
59. FAN X, Yin C, Wang J, Yang M, et al
    Pre-diagnostic circulating concentrations of insulin-like growth factor-1 and risk of COVID-19 mortality: results from UK Biobank.
    Eur J Epidemiol. 2021;36:311-318.
    PubMed     Abstract available
    
    
    February 2021
60. PEARCE N, Vandenbroucke JP
    Arguments about face masks and Covid-19 reflect broader methodologic debates within medical science.
    Eur J Epidemiol. 2021;36:143-147.
    PubMed     Abstract available
    
    
    
61. SKJEFTE M, Ngirbabul M, Akeju O, Escudero D, et al
    COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.
    Eur J Epidemiol. 2021;36:197-211.
    PubMed     Abstract available
    
    
    
62. ACCORSI EK, Qiu X, Rumpler E, Kennedy-Shaffer L, et al
    How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19.
    Eur J Epidemiol. 2021;36:179-196.
    PubMed     Abstract available
    
    
    
63. CARRAT F, Figoni J, Henny J, Desenclos JC, et al
    Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.
    Eur J Epidemiol. 2021;36:219-222.
    PubMed     Abstract available
    
    
    
64. GIANICOLO EAL, Russo A, Buchler B, Taylor K, et al
    Gender specific excess mortality in Italy during the COVID-19 pandemic accounting for age.
    Eur J Epidemiol. 2021;36:213-218.
    PubMed     Abstract available
    
    
    January 2021
65. PEARCE N, Moirano G, Maule M, Kogevinas M, et al
    Does death from Covid-19 arise from a multi-step process?
    Eur J Epidemiol. 2021;36:1-9.
    PubMed     Abstract available
    
    
    December 2020
66. LEVIN AT, Hanage WP, Owusu-Boaitey N, Cochran KB, et al
    Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.
    Eur J Epidemiol. 2020;35:1123-1138.
    PubMed     Abstract available
    
    
    November 2020
67. GOMEZ-OCHOA SA, Franco OH
    COVID-19: facts and failures, a tale of two worlds.
    Eur J Epidemiol. 2020;35:991-994.
    PubMed    
    
    
    
68. CATALANO R, Casey JA, Bruckner TA, Gemmill A, et al
    Non-COVID-19 deaths after social distancing in Norway.
    Eur J Epidemiol. 2020;35:1021-1024.
    PubMed     Abstract available
    
    
    
69. HANAGE WP, Testa C, Chen JT, Davis L, et al
    COVID-19: US federal accountability for entry, spread, and inequities-lessons for the future.
    Eur J Epidemiol. 2020;35:995-1006.
    PubMed     Abstract available
    
    
    
70. MILLS EHA, Moller AL, Gnesin F, Zylyftari N, et al
    National all-cause mortality during the COVID-19 pandemic: a Danish registry-based study.
    Eur J Epidemiol. 2020;35:1007-1019.
    PubMed     Abstract available
    
    
    
71. HUANG J, Teoh JY, Wong SH, Wong MCS, et al
    The potential impact of previous exposure to SARS or MERS on control of the COVID-19 pandemic.
    Eur J Epidemiol. 2020;35:1099-1103.
    PubMed     Abstract available
    
    
    June 2020
72. LIPSITCH M
    Good science is good science: we need specialists, not sects.
    Eur J Epidemiol. 2020;35:519-522.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: